Company / Gross Profit
Emergent BioSolutions Inc. Gross Profit History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$317.6M
FY2023
5-year range
$317.6M / $891.3M
FY2019-FY2023
Trend
-17.1%
vs FY2022
Sector context
#18 of 29
Health Care
What the data says
At $318M, Emergent BioSolutions Inc.'s gross profit ranks #18 of 29 in the Health Care sector. Gross Profit has declined for 3 consecutive years, from $916M in FY2020 to $318M in FY2023.
Based on SEC 10-K filings.
$318M in FY2023 with a 3-year CAGR of -29.8%.
Declined from $891M to $318M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -29.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#18 of 29 in Health CareTop 62% of 29This company $317.6M Sector average $3.5B
▼
-90.8% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s gross profit has declined for 3 consecutive years.
- 3-year CAGR of -29.8%, indicating a declining trend.
- In FY2023, gross profit decreased 17.1% year-over-year.
- Ranks #18 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $317.6M | -17.1% |
| FY2022 | $383.0M | -57.0% |
| FY2021 | $891.3M | -2.7% |
| FY2020 | $916.3M | - |
| FY2019 | - | - |
| FY2018 | -$9.5M | -163.7% |
| FY2017 | $14.9M | -29.5% |
| FY2016 | $21.2M | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026